BiomX PHGE
NYSE PHGE
$1.67 +0.12 (+7.74%)
As of: Sep 9, 2026 · 3:59 PM EDT

BiomX (PHGE) Short term Debt (2019 - 2026)

BiomX's (PHGE) quarterly Short term Debt came in at $210000.0 in Q2 2026, down 96.37% quarter-over-quarter from $5.8 million in Q4 2023.

Analysis

BiomX (PHGE) Short term Debt (2019 - 2026) Analysis & Trends

BiomX has disclosed Short term Debt across 6 years of filings, most recently posting $210000.0 for Q2 2026.

  • In Q2 2026, Short term Debt changed N/A year-over-year to $210000.0; the TTM figure through Jun 2026 stood at $210000.0 (changed N/A YoY), while the FY2023 annual figure was $5.8 million, up 35.1% from the prior year.
  • Short term Debt came in at $210000.0 for Q2 2026 at BiomX, down from $5.8 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $5.8 million in Q4 2023 to a low of $210000.0 in Q2 2026.
  • Average Short term Debt over 3 years is $1.6 million, with a median of $687000.0 recorded in 2022.
  • Year-over-year, Short term Debt surged 422.83% in 2022 and dropped 15.32% in 2023.
  • Over 3 years, Short term Debt stood at $4.3 million in 2022, then soared by 35.1% to $5.8 million in 2023, then slumped by 96.37% to $210000.0 in 2026.
  • Per Business Quant data, the three most recent Short term Debt figures were $210000.0 in Q2 2026, $5.8 million in Q4 2023, and $632000.0 in Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 BiomX 1.55 Mn 7.73 Mn 97,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 210,000.00
Dec 31, 2023 5.79 Mn
Sep 30, 2023 632,000.00
Jun 30, 2023 654,000.00
Mar 31, 2023 669,000.00
Dec 31, 2022 4.28 Mn
Sep 30, 2022 687,000.00
Jun 30, 2022 708,000.00
Mar 31, 2022 790,000.00
Dec 31, 2021 819,000.00
Sep 30, 2021 799,000.00
Jun 30, 2021 791,000.00
Mar 31, 2021 763,000.00
Dec 31, 2020 863,000.00
Sep 30, 2020 594,000.00
Jun 30, 2020 369,000.00
Mar 31, 2020 361,000.00
Dec 31, 2019 375,000.00